Pharmaceuticals

Rheumatoid Arthritis Market Growth, Size, Share and Forecast 2019-2025

May 19, 2020 by OMRGlobal

The global rheumatoid arthritis market is projected to exhibit a significant growth, at a CAGR of around 5.2%, during the forecast period. Changing the lifestyle of the people is a significant cause of rheumatoid arthritis. The trend of smoking, drinking alcohol and unhealthy eating activity is increasing among people, which is a major risk for the development of rheumatoid arthritis. Due to unhealthy eating habits, people are prone to type 1 diabetes, which is considered a cause of rheumatoid arthritis. With the increasing prevalence of diabetes, measures for diagnosis and treatment are growing at a significant rate, thus, supporting the global rheumatoid arthritis market.

A full report of Global Rheumatoid Arthritis Market is available at:  https://www.omrglobal.com/industry-reports/rheumatoid-arthritis-market

Smoking habits make a person more vulnerable to greater risk of rheumatoid arthritis. Moreover, tobacco consumption is increasing in both the emerging and developed economies of the world. Tobacco product includes cigarettes, cigars, pipes, chewing tobacco, and snuff. As per American Lung Association, average smoker smokes 15 cigarettes per day in the US. Similar trends can be observed in other countries of Europe and in China and Australia. As per Institute of Health Metrics and Evaluation (IHME) Organization, there were around 2.6 million deaths in 1990 combinedly in the US, UK, India, China, Germany, and Canada due to smoking of tobacco. In 2016, it was estimated to be 3.2 million mortalities due to smoking in the following countries. Multiple studies have indicated that smoking increases a person’s risk of developing rheumatoid arthritis and can make the disease worse.

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/rheumatoid-arthritis-market

Lack of physical inactivity, lack of awareness, and smoking are some of the major factors accounted for the rise in chronic diseases across the globe. Furthermore, diabetes is known as the world’s fastest growing lifestyle-oriented disease. A significant rise has witnessed in the diabetic population. According to the World Health Organization (WHO), diabetes prevalence has been increasing steadily over the past three decades. In 1980, the diabetic population totaled around 108 million and this number has increased to 415 million in 2015, as per the International Diabetes Federation (IDF). These numbers specify that in present times every 1 in 11 adults will be affected by diabetes. According to the IDF, the diabetic population is projected to reach 642 million by 2040. Such large prevalence of diabetes increases the risk of rheumatoid arthritis. According to the Arthritis Foundation, around half of adults having diabetes also have rheumatoid arthritis. This, in turn, is offering growth to the global rheumatoid arthritis market.

Moreover, the people have developed sedentary lifestyles and greater rates of obesity, where, the obesity is regarded as one of the major lifestyle-oriented disease. Being obese doubles the risk for the development of rheumatoid arthritis. According to the World Health Organization (WHO), in 2016, there are over 1.9 billion people, aged 18 years and above, are categorized in overweight population, among which, over 650 million (13%) are categorized as obese and around 39% of adults as overweight. Obesity leads to the development of rheumatoid arthritis; therefore, the increasing obese population is driving the global rheumatoid arthritis market.

Global Rheumatoid Arthritis Market-Segmentation

By Product Type
  • Medications
o   Nonsteroidal anti-inflammatory drugs (NSAIDs)
o   Disease-modifying anti-rheumatic drugs (DMARDs)
o   Biologics
o   Steroidal Medications
  • Surgery
For more customized data, request for report customization @  https://www.omrglobal.com/report-customization/rheumatoid-arthritis-market

Global Rheumatoid Arthritis Market– Segment by Region

North America          
  • United States
  • Canada
Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific   
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
Rest of the World
  • Middle East & Africa
  • Latin America
Company Profiles
  • AbbVie Inc.
  • Allergan PLC
  • Amgen Inc.
  • Anika Therapeutics, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co.
  • Celltrion Healthcare Co.,Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA
  • Swedish Orphan Biovitrum AB (SOBI)
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research


Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404

0 Comments

0 Comments

Post a Comment